Similar articles for PMID: 26449837

Year	Number of Results
1991	1
1993	2
1994	1
1998	2
2001	1
2002	2
2004	2
2007	2
2008	6
2009	7
2010	3
2011	12
2012	13
2013	20
2014	18
2015	24
2016	31
2017	38
2018	40
2019	34
2020	35
2021	50
2022	36
2023	10
2024	0

1

Phase I Study of 68Ga-HER2-Nanobody for PET/CT Assessment of HER2 Expression in Breast Carcinoma.

Keyaerts M, Xavier C, Heemskerk J, Devoogdt N, Everaert H, Ackaert C, Vanhoeij M, Duhoux FP, Gevaert T, Simon P, Schallier D, Fontaine C, Vaneycken I, Vanhove C, De Greve J, Lamote J, Caveliers V, Lahoutte T. Keyaerts M, et al. J Nucl Med. 2016 Jan;57(1):27-33. doi: 10.2967/jnumed.115.162024. Epub 2015 Oct 8. J Nucl Med. 2016. PMID: 26449837 Free article. Clinical Trial.

2

Synthesis, preclinical validation, dosimetry, and toxicity of 68Ga-NOTA-anti-HER2 Nanobodies for iPET imaging of HER2 receptor expression in cancer.

Xavier C, Vaneycken I, D'huyvetter M, Heemskerk J, Keyaerts M, Vincke C, Devoogdt N, Muyldermans S, Lahoutte T, Caveliers V. Xavier C, et al. J Nucl Med. 2013 May;54(5):776-84. doi: 10.2967/jnumed.112.111021. Epub 2013 Mar 13. J Nucl Med. 2013. PMID: 23487015 Free article.

3

Biodistribution and Radiation Dosimetry of the Anti-HER2 Affibody Molecule 68Ga-ABY-025 in Breast Cancer Patients.

Sandström M, Lindskog K, Velikyan I, Wennborg A, Feldwisch J, Sandberg D, Tolmachev V, Orlova A, Sörensen J, Carlsson J, Lindman H, Lubberink M. Sandström M, et al. J Nucl Med. 2016 Jun;57(6):867-71. doi: 10.2967/jnumed.115.169342. Epub 2016 Feb 9. J Nucl Med. 2016. PMID: 26912439 Free article.

4

First-in-Human Human Epidermal Growth Factor Receptor 2-Targeted Imaging Using ⁸⁹Zr-Pertuzumab PET/CT: Dosimetry and Clinical Application in Patients with Breast Cancer.

Ulaner GA, Lyashchenko SK, Riedl C, Ruan S, Zanzonico PB, Lake D, Jhaveri K, Zeglis B, Lewis JS, O'Donoghue JA. Ulaner GA, et al. J Nucl Med. 2018 Jun;59(6):900-906. doi: 10.2967/jnumed.117.202010. Epub 2017 Nov 16. J Nucl Med. 2018. PMID: 29146695 Free PMC article. Clinical Trial.

5

First-in-human molecular imaging of HER2 expression in breast cancer metastases using the 111In-ABY-025 affibody molecule.

Sörensen J, Sandberg D, Sandström M, Wennborg A, Feldwisch J, Tolmachev V, Åström G, Lubberink M, Garske-Román U, Carlsson J, Lindman H. Sörensen J, et al. J Nucl Med. 2014 May;55(5):730-5. doi: 10.2967/jnumed.113.131243. Epub 2014 Mar 24. J Nucl Med. 2014. PMID: 24665085 Free article. Clinical Trial.

6

(18)F-nanobody for PET imaging of HER2 overexpressing tumors.

Xavier C, Blykers A, Vaneycken I, D'Huyvetter M, Heemskerk J, Lahoutte T, Devoogdt N, Caveliers V. Xavier C, et al. Nucl Med Biol. 2016 Apr;43(4):247-52. doi: 10.1016/j.nucmedbio.2016.01.002. Epub 2016 Jan 23. Nucl Med Biol. 2016. PMID: 27067045

7

Measuring HER2-Receptor Expression In Metastatic Breast Cancer Using [68Ga]ABY-025 Affibody PET/CT.

Sörensen J, Velikyan I, Sandberg D, Wennborg A, Feldwisch J, Tolmachev V, Orlova A, Sandström M, Lubberink M, Olofsson H, Carlsson J, Lindman H. Sörensen J, et al. Theranostics. 2016 Jan 1;6(2):262-71. doi: 10.7150/thno.13502. eCollection 2016. Theranostics. 2016. PMID: 26877784 Free PMC article.

8

Preclinical Evaluation of 18F-Labeled Anti-HER2 Nanobody Conjugates for Imaging HER2 Receptor Expression by Immuno-PET.

Vaidyanathan G, McDougald D, Choi J, Koumarianou E, Weitzel D, Osada T, Lyerly HK, Zalutsky MR. Vaidyanathan G, et al. J Nucl Med. 2016 Jun;57(6):967-73. doi: 10.2967/jnumed.115.171306. Epub 2016 Feb 18. J Nucl Med. 2016. PMID: 26912425 Free PMC article.

9

68Ga-NOTA-Aca-BBN(7-14) PET/CT in Healthy Volunteers and Glioma Patients.

Zhang J, Li D, Lang L, Zhu Z, Wang L, Wu P, Niu G, Li F, Chen X. Zhang J, et al. J Nucl Med. 2016 Jan;57(1):9-14. doi: 10.2967/jnumed.115.165316. Epub 2015 Oct 8. J Nucl Med. 2016. PMID: 26449838 Free PMC article. Clinical Trial.

10

Functional imaging of human epidermal growth factor receptor 2-positive metastatic breast cancer using (64)Cu-DOTA-trastuzumab PET.

Mortimer JE, Bading JR, Colcher DM, Conti PS, Frankel PH, Carroll MI, Tong S, Poku E, Miles JK, Shively JE, Raubitschek AA. Mortimer JE, et al. J Nucl Med. 2014 Jan;55(1):23-9. doi: 10.2967/jnumed.113.122630. Epub 2013 Dec 12. J Nucl Med. 2014. PMID: 24337604 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

321 results

Results by year